$SERV
Serve Robotics Inc. /DE/ Stock $serv

$serv Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000121390024043174 Filed on May 15, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q4
Revenue	$468.4K	$946.7K	$42.72K
YoY Change
Cost Of Revenue	$326.0K	$352.4K	$399.1K
YoY Change	-57.03%	-4.04%
Gross Profit	$142.4K	$594.3K	-$356.4K
YoY Change	-121.69%	-281.73%
Gross Profit Margin	30.39%	62.77%	-834.22%
Selling, General & Admin	$2.039M	$1.126M	$2.509M
YoY Change	-41.14%	286.96%
% of Gross Profit	1432.22%	189.53%
Research & Development	$5.788M	$6.638M	$2.712M
YoY Change	37.52%	218.7%
% of Gross Profit	4065.63%	1117.07%
Depreciation & Amortization	$9.577K	$17.92K	$467.0K
YoY Change	-98.97%	-96.15%
% of Gross Profit	6.73%	3.02%
Operating Expenses	$8.698M	$8.306M	$4.996M
YoY Change	13.37%	112.96%
Operating Profit	-$8.556M	-$7.711M	-$5.352M
YoY Change	47860.58%	67061.2%
Interest Expense	-$260.1K	$1.327M	-$242.4K
YoY Change	-85.35%	3077.75%
% of Operating Profit
Other Income/Expense, Net	-$481.7K	-$1.327M	$0.00
YoY Change	-44.29%	45.63%
Pretax Income	-$9.037M	-$9.038M	-$7.063M
YoY Change	-10.56%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	-$9.037M	-$9.038M	-$7.063M
YoY Change	50560.73%	78614.26%
Net Earnings / Revenue	-1929.52%	-954.67%	-16534.15%
Basic Earnings Per Share	-$0.27	-$0.37
Diluted Earnings Per Share	-$0.27	-$0.37	-$0.19
COMMON SHARES
Basic Shares Outstanding	37.08M shares	24.56M shares	24.83M shares
Diluted Shares Outstanding	33.80M shares	24.56M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$28.78M	$427.5K	$6.760K
YoY Change	152094.76%
Cash & Equivalents	$28.78M	$427.5K	$6.756K
Short-Term Investments
Other Short-Term Assets	$1.120M	$1.603M	$677.0K
YoY Change	168.13%
Inventory	$709.3K	$736.5K	$774.3K
Prepaid Expenses	$1.120M	$629.6K	$677.0K
Receivables	$93.13K	$266.0K	$2.955K
Other Receivables	$180.0K	$0.00	$0.00
Total Short-Term Assets	$30.88M	$3.033M	$1.461M
YoY Change	334270.4%	24428.13%	319600.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$819.2K	$33.84K	$48.42K
YoY Change	-76.24%		-98.57%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$512.7K	$512.7K	$512.7K
YoY Change	0.0%
Total Long-Term Assets	$1.884M	$1.215M	$1.344M
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$30.88M	$3.033M	$1.461M
Total Long-Term Assets	$1.884M	$1.215M	$1.344M
Total Assets	$32.77M	$4.248M	$2.805M
YoY Change	354669.34%	34253.13%	613586.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.388M	$1.725M	$2.051M
YoY Change	12990.18%	10755.6%	20406.05%
Accrued Expenses	$46.08K	$1.151M	$255.8K
YoY Change	-92.57%		583.47%
Deferred Revenue	$52.86K		$0.00
YoY Change
Short-Term Debt	$0.00	$4.549M	$70.00K
YoY Change	-100.0%
Long-Term Debt Due	$2.367M	$3.336M	$3.364M
YoY Change	-27.63%
Total Short-Term Liabilities	$4.268M	$12.79M	$6.237M
YoY Change	2532.65%	8580.29%	4930.02%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$230.9K
YoY Change	-100.0%
Other Long-Term Liabilities	$35.23K	$260.3K	$369.8K
YoY Change	-99.8%
Total Long-Term Liabilities	$35.23K	$260.3K	$600.7K
YoY Change	-99.81%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.268M	$12.79M	$6.237M
Total Long-Term Liabilities	$35.23K	$260.3K	$600.7K
Total Liabilities	$4.303M	$13.05M	$6.838M
YoY Change	2554.38%	8756.87%	5414.48%
SHAREHOLDERS EQUITY
Retained Earnings	-$86.41M	-$77.37M	-$68.33M
YoY Change	56242.9%	56990.83%	54989.27%
Common Stock	$3.651K	$2.462K	$2.450K
YoY Change	630.2%	392.4%	390.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$28.46M	-$8.806M	-$4.033M
YoY Change
Total Liabilities & Shareholders Equity	$32.77M	$4.248M	$2.805M
YoY Change	354669.34%	34253.13%	613586.87%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	-$9.037M	-$9.038M	-$7.063M
YoY Change	50560.73%	78614.26%
Depreciation, Depletion And Amortization	$9.577K	$17.92K	$467.0K
YoY Change	-98.97%	-96.15%
Cash From Operating Activities	-$5.742M	-$4.078M	-$3.677M
YoY Change	-12.87%	72845.45%
INVESTING ACTIVITIES
Capital Expenditures	$795.0K	$3.340K	$2.420K
YoY Change
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change
Cash From Investing Activities	-$795.0K	-$3.340K	-$2.420K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	34.89M	$4.502M	183.6K
YoY Change	796.12%	25628.26%
NET CHANGE
Cash From Operating Activities	-5.742M	-$4.078M	-3.677M
Cash From Investing Activities	-795.0K	-$3.340K	-2.420K
Cash From Financing Activities	34.89M	$4.502M	183.6K
Net Change In Cash	28.35M	$420.7K	-3.495M
YoY Change	-1151.34%	3432.84%
FREE CASH FLOW
Cash From Operating Activities	-$5.742M	-$4.078M	-$3.677M
Capital Expenditures	$795.0K	$3.340K	$2.420K
Free Cash Flow	-$6.537M	-$4.082M	-$3.679M
YoY Change	-0.81%	72905.19%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.37
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24556343	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.77
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	000-56237
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	SERVE ROBOTICS INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-3844872
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	730 Broadway
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Redwood City
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94063
CY2024Q1	dei	City Area Code CityAreaCode	(818)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	860-1352
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2024Q1	dei	Trading Symbol TradingSymbol	SERV
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	37080717	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2450	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	68729393	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	427482	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6756	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	266030	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2955	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	736535	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	774349	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	629610	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	676969	usd
CY2024Q1	us-gaap	Deferred Costs Current DeferredCostsCurrent	973491	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	3033148	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1461029	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	33839	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	48422	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	668462	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	782439	usd
CY2024Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	512659	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	512659	usd
CY2024Q1	us-gaap	Assets Assets	4248108	usd
CY2023Q4	us-gaap	Assets Assets	2804549	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1725064	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2050605	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1151158	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	255849	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	68899	usd
CY2024Q1	us-gaap	Notes Payable Current NotesPayableCurrent	1000000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1000000	usd
CY2024Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	4549395	usd
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1489000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	474649	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	496963	usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2335796	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2363807	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	12793961	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6237224	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	230933	usd
CY2024Q1	patr	Restricted Stock Award Liability RestrictedStockAwardLiability	154630	usd
CY2023Q4	patr	Restricted Stock Award Liability RestrictedStockAwardLiability	158617	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	105643	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	211181	usd
CY2024Q1	us-gaap	Liabilities Liabilities	13054234	usd
CY2023Q4	us-gaap	Liabilities Liabilities	6837955	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24957814	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24832814	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24633795	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24508795	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	2462	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	64468141	usd
CY2024Q1	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	165629	usd
CY2023Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	169616	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-77372352	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-68334381	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-8806126	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-4033406	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4248108	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2804549	usd
CY2024Q1	us-gaap	Revenues Revenues	946711	usd
CY2023Q1	us-gaap	Revenues Revenues	40252	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	352438	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	367261	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	594273	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	-327009	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1008071	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1015987	usd
CY2024Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	540974	usd
CY2023Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	521687	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6638441	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2082949	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	118236	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	279582	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	8305722	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	3900205	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-7711449	usd
CY2024Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	5832	usd
CY2024Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	250000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4227214	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	1326522	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	41744	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	869164	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1326522	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-910908	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-9037971	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5138122	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24556343	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6708450	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.77
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-12452146	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	2234	usd
CY2023Q1	patr	Stock Issued During Period Value Restricted Stock Awards Repurchased StockIssuedDuringPeriodValueRestrictedStockAwardsRepurchased	-24	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	93943	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5138122	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-17494115	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-4033406	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5832	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	3987	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	4255432	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-9037971	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-8806126	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-9037971	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5138122	usd
CY2024Q1	us-gaap	Depreciation Depreciation	17923	usd
CY2023Q1	us-gaap	Depreciation Depreciation	465640	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4255432	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	93943	usd
CY2024Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1212836	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	869164	usd
CY2024Q1	patr	Interest On Recourse Loan InterestOnRecourseLoan	-3987	usd
CY2023Q1	patr	Interest On Recourse Loan InterestOnRecourseLoan	1202	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	263075	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-8626	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-37814	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4704	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-47359	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	33643	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-325541	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	64191	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-82168	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-30239	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	68899	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-13875	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-11063	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4078380	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3713409	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3340	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3340	usd
CY2023Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	2666953	usd
CY2024Q1	patr	Proceeds From Lease Liability Financing ProceedsFromLeaseLiabilityFinancing	4844625	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	250000	usd
CY2024Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	70000	usd
CY2024Q1	patr	Repayment Of Lease Liability Financing RepaymentOfLeaseLiabilityFinancing	28011	usd
CY2023Q1	patr	Repayment Of Lease Liability Financing RepaymentOfLeaseLiabilityFinancing	552786	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4502446	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1864167	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	420726	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1849242	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6756	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2715719	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	427482	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	866477	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	35892	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	40630	usd
CY2023Q1	patr	Vested Restricted Stock Purchased With Recourse Notes VestedRestrictedStockPurchasedWithRecourseNotes	3436	usd
CY2024Q1	patr	Deferred Offering Costs Included In Accounts Payable DeferredOfferingCostsIncludedInAccountsPayable	973491	usd
CY2024Q1	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>1. NATURE OF OPERATIONS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Serve Operating Co. (“Serve”) (formerly known as Serve Robotics Inc.) is a corporation formed on January 15, 2021 under the laws of the State of Delaware.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 31, 2023, Patricia’s wholly-owned subsidiary, Serve Acquisition Corp., a corporation formed in the State of Delaware on July 10, 2023 (“Acquisition Sub”), merged with and into the Company (as defined below). Pursuant to this transaction (the “Merger”), Serve was the surviving corporation and became Patricia’s wholly owned subsidiary, and all of the outstanding stock of Serve was converted into shares of Patricia’s common stock. All of Serve’s outstanding warrants and options were assumed by Patricia. In addition, on July 31, 2023, the board of directors of Patricia Acquisition Corp., a Delaware corporation incorporated on November 9, 2020 (“Patricia”) and all of its pre-Merger stockholders approved a restated certificate of incorporation, which was effective upon its filing with the Secretary of State of the State of Delaware on July 31, 2023, and through which Patricia changed its name to “Serve Robotics Inc.” Following the consummation of the Merger, Serve changed its name to “Serve Operating Co.”</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of the Merger, Patricia acquired the business of Serve and will continue the existing business operations of Serve as a public reporting company under the name Serve Robotics Inc. (the “Company”). The Company is developing autonomous robots for last-mile delivery services. The Company is headquartered in Redwood City, California. In accordance with “reverse merger” or “reverse acquisition” accounting treatment, the Company was determined the accounting acquirer. Patricia’s historical financial statements before the Merger have been replaced with the historical financial statements of Serve before the Merger in filings with the SEC since the Merger unless otherwise noted.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Public Offering</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 17, 2024, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with Aegis Capital Corp. (“Aegis”) in connection with the public offering of 10,000,000 shares of the Company’s common stock, par value $0.0001, at a public offering price of $4.00 per share (the “Offering”). The Company’s net proceeds from the Offering, after deducting the underwriting discount and other estimated offering expenses payable by the Company, were approximately $35.7 million. As a result of the Offering, the Company’s Common Stock was approved for listing on The Nasdaq Capital Market and commenced trading under the ticker symbol “SERV” beginning on April 18, 2024. See Note 11.</p>
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-9037971	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5138122	usd
CY2024Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	35700000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Use of Estimates</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the Company’s financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions reflected in these financial statements include, but are not limited to, the valuations of common stock and options. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates when there are changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates.</p>
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Concentrations of Credit Risk</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company generally maintains balances in various operating accounts at financial institutions that management believes to be of high credit quality, in amounts that may exceed federally insured limits. The Company has not experienced any losses related to its cash and cash equivalents and does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. As of March 31, 2024 and December 31, 2023, all of the Company’s cash and cash equivalents were held at one accredited financial institution.</p>
CY2024Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts	973491	usd
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue	68899	usd
CY2024Q1	us-gaap	Payments For Software PaymentsForSoftware	851101	usd
CY2024Q1	patr	Delivery Services DeliveryServices	51760	usd
CY2023Q1	patr	Delivery Services DeliveryServices	25252	usd
CY2024Q1	patr	Branding Fees Expense BrandingFeesExpense	43850	usd
CY2023Q1	patr	Branding Fees Expense BrandingFeesExpense	15000	usd
CY2024Q1	us-gaap	Revenues Revenues	946711	usd
CY2023Q1	us-gaap	Revenues Revenues	40252	usd
CY2024Q1	us-gaap	Advertising Expense AdvertisingExpense	16000	usd
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	184000	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7040194	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9574651	shares
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1489000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2346294	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2342954	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2312455	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2294532	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	33839	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	48422	usd
CY2024Q1	us-gaap	Depreciation Depreciation	17923	usd
CY2023Q1	us-gaap	Depreciation Depreciation	465640	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	14984	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	19067	usd
CY2024Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	250000	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	250000	usd
CY2023	us-gaap	Proceeds From Commissions Received ProceedsFromCommissionsReceived	70000	usd
CY2023Q4	us-gaap	Investment Interest Rate InvestmentInterestRate	0.0767	pure
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	169875	usd
CY2024Q1	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	80000000	shares
CY2024Q1	patr	Debt Discount DebtDiscount	1658875	usd
CY2024Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1193770	usd
CY2024Q1	patr	Unamortized Discount Balance UnamortizedDiscountBalance	465105	usd
CY2024Q1	patr	Unamortized Discount Outstanding UnamortizedDiscountOutstanding	4549395	usd
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	62681	usd
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022	patr	Shares Of Restricted Common Stock Issued SharesOfRestrictedCommonStockIssued	338121	shares
CY2022	patr	Restricted Common Stock For Recourse Notes RestrictedCommonStockForRecourseNotes	164116	usd
CY2024Q1	patr	Vesting Of Restricted Common Stock VestingOfRestrictedCommonStock	41303	usd
CY2023Q1	patr	Vesting Of Restricted Common Stock VestingOfRestrictedCommonStock	71362	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1090272	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.67
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	2145000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.01
CY2024Q1	patr	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised	125000	shares
CY2024Q1	patr	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsExercised	0
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	3110272	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.94
CY2024Q1	patr	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable	965272	shares
CY2024Q1	patr	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Price Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsPriceExercisable	3.02
CY2024Q1	patr	Placement Agent Warrants Were Exercised PlacementAgentWarrantsWereExercised	125000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1515386	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.61
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5111928	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	14045	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.5
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1501341	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.61
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5062741	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	853478	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.61
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	2865304	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1501341	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	0.61
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	5062741	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4255432	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	93943	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	100739	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	209386	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	139077	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	136266	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y18D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y3M18D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0725	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0725	pure
CY2024Q1	patr	Outstanding Liability OutstandingLiability	2335796	usd
CY2024Q1	us-gaap	Property Plant And Equipment Salvage Value Percentage PropertyPlantAndEquipmentSalvageValuePercentage	0.45	pure
CY2021Q4	patr	Purchases Over Obligation PurchasesOverObligation	2300000	usd
CY2024Q1	patr	Purchases Over Obligation PurchasesOverObligation	2300000	usd
CY2024Q1	patr	Price Paid Per Share PricePaidPerShare	2104562	shares
CY2024Q1	us-gaap	Shares Issued SharesIssued	63479	shares
CY2024Q1	us-gaap	Stock Option Exercise Price Decrease StockOptionExercisePriceDecrease	2.42
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	patr	Non Rule10b51 Arrangement Modification NonRule10b51ArrangementModification	false
CY2024Q1	patr	Rule10b51 Arrangement Modification Rule10b51ArrangementModification	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent		usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent		usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent		usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2024Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6708450	shares
CY2024Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2024Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity		usd
CY2023Q1	patr	Proceeds From Lease Liability Financing ProceedsFromLeaseLiabilityFinancing		usd
CY2023Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2024Q1	patr	Vested Restricted Stock Purchased With Recourse Notes VestedRestrictedStockPurchasedWithRecourseNotes		usd
CY2023Q1	patr	Deferred Offering Costs Included In Accounts Payable DeferredOfferingCostsIncludedInAccountsPayable		usd
CY2023Q1	us-gaap	Payments For Software PaymentsForSoftware		usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001832483

Files In Submission

Name	View Source	Status
0001213900-24-043174-index-headers.html	Edgar Link	pending
0001213900-24-043174-index.html	Edgar Link	pending
0001213900-24-043174.txt	Edgar Link	pending
0001213900-24-043174-xbrl.zip	Edgar Link	pending
ea0205869-10q_serverobo.htm	Edgar Link	pending
ea020586901ex10-5_serverobo.htm	Edgar Link	pending
ea020586901ex31-1_serverobo.htm	Edgar Link	pending
ea020586901ex31-2_serverobo.htm	Edgar Link	pending
ea020586901ex32-1_serverobo.htm	Edgar Link	pending
ea020586901ex32-2_serverobo.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
patr-20240331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
patr-20240331_def.xml	Edgar Link	unprocessable
patr-20240331_cal.xml	Edgar Link	unprocessable
patr-20240331_pre.xml	Edgar Link	unprocessable
patr-20240331_lab.xml	Edgar Link	unprocessable
ea0205869-10q_serverobo_htm.xml	Edgar Link	completed
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SERV
Serve Robotics Inc. /DE/ Stock $serv

2024 Q2 Form 10-Q Financial Statement

#000121390024043174 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SERV Serve Robotics Inc. /DE/ Stock $serv

2024 Q2 Form 10-Q Financial Statement

#000121390024043174 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SERV
Serve Robotics Inc. /DE/ Stock $serv